Which Post-Delivery drug is safer for the heart? new study compares carbetocin and oxytocin
NCT ID NCT03899961
First seen Feb 13, 2026 · Last updated Jun 21, 2026 · Updated 16 times
Summary
This study compared two drugs, carbetocin and oxytocin, given to healthy pregnant women after delivery to prevent heavy bleeding. The goal was to see if one causes less heart strain than the other. 240 women participated, and researchers measured heart damage markers and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital
Lørenskog, Norway
-
Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
Oslo, 0027, Norway
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Carbetocin and oxytocin (drugs given after childbirth to prevent bleeding)
What this could lead to
If carbetocin is safer for the heart, it could become the preferred drug for preventing bleeding after delivery, especially in women with heart conditions.
What could go wrong
This is a small, completed study in healthy women, so results may not apply to all pregnant women. Both drugs are already in use and considered safe, so major differences are unlikely.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.